a:head closes another 7-digit EUR financing round
a:head bio AG today closed a second round of financing to fuel its revolutionary approach in combating neurological…
Evologic Technologies: €2,5 million through a new financing round
Financial investments secure the production of biostimulants and biopesticides through a novel, sustainable, and…
EyeGate Pharma Announces Transformative Acquisition of Panoptes Pharma
- Expands Pipeline Beyond Ophthalmology with PP-001, a Clinical Stage, Best-in-Class DHODH Inhibitor
- PP-001 Leverages…
Biomay to construct a new biotech manufacturing facility in Vienna
Tenfold Increase of manufacturing capacities in 2022
HOOKIPA Pharma Announces Closing of Public Offering of $80.9 Million of Common Stock and Preferred Stock, Including Full Exercise of Underwriters’ Option
HOOKIPA Pharma Inc. (Nasdaq: HOOK), a company developing a new class of immunotherapeutics based on its proprietary…
QUANTRO Therapeutics Launched with Breakthrough Oncology Drug Discovery Platform
- QUANTRO to enable discovery of novel therapeutics that interfere with disease-causing transcriptional programs in…